TETRA Technologies, Inc. (TTI)

Regulus Therapeutics Stock Forecast

Stock Price Forecast

The 2 analysts that cover Regulus Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $5.75, which forecasts a 47.81% increase in the stock price over the next year. The lowest target is $5.00 and the highest is $6.50.

Price Target: $5.75 (+47.81%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$5.00	$5.75	$6.50	$6.50
Change	+28.53%	+47.81%	+67.10%	+67.10%

Analyst Ratings

The average analyst rating for Regulus Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Feb '25	Mar '25	Apr '25	May '25	Jun '25	Jul '25
Strong Buy	3	2	3	3	3	2
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	2	3	3	3	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Stephen Gengaro Stifel	Stifel	Strong Buy Maintains $6 → $6.5	Strong Buy	Maintains	$6 → $6.5	+67.10%	Jul 31, 2025
Jesse Sobelson D. Boral Capital	D. Boral Capital	Strong Buy Maintains $4 → $5	Strong Buy	Maintains	$4 → $5	+28.53%	Jul 31, 2025
Stephen Gengaro Stifel	Stifel	Strong Buy Maintains $6.5 → $6	Strong Buy	Maintains	$6.5 → $6	+54.24%	Jul 16, 2025
Jesse Sobelson D. Boral Capital	D. Boral Capital	Strong Buy Maintains $5.5 → $4	Strong Buy	Maintains	$5.5 → $4	+2.83%	May 1, 2025
Stephen Gengaro Stifel	Stifel	Strong Buy Maintains $7 → $6.5	Strong Buy	Maintains	$7 → $6.5	+67.10%	Apr 15, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

609.30M

Increased by 1.70%

from 599.11M

Revenue Next Year

640.78M

Increased by 5.17%

from 609.30M

EPS This Year

0.24

Decreased by -70.67%

from 0.82

EPS Next Year

0.37

Increased by 54.41%

from 0.24

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	377.72M	388.27M	553.21M	626.26M	599.11M	609.30M	640.78M	958.04M
Revenue Growth	-32.70%	2.80%	42.48%	13.20%	-4.34%	1.70%	5.17%	49.51%
EPS	-0.41	0.82	0.06	0.20	0.82	0.24	0.37	0.84
EPS Growth	-	-	-92.50%	225.15%	311.87%	-70.67%	54.41%	125.85%
Forward PE	-	-	-	-	-	16.18	10.48	4.64
No. Analysts	-	-	-	-	-	5	5	2

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028
High	644.1M	698.4M	996.0M
Avg	609.3M	640.8M	958.0M
Low	583.4M	600.1M	929.6M

Revenue Growth

Revenue Growth	2025	2026	2027	2028
High	7.5%	14.6%	55.4%
Avg	1.7%	5.2%	49.5%
Low	-2.6%	-1.5%	45.1%

EPS Forecast

EPS	2025	2026	2027	2028
High	0.25	0.41	0.87
Avg	0.24	0.37	0.84
Low	0.23	0.34	0.81

EPS Growth

EPS Growth	2025	2026	2027	2028
High	-69.3%	70.4%	134.8%
Avg	-70.7%	54.4%	125.9%
Low	-71.8%	40.7%	119.1%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.